Acadia Healthcare Company, Inc. (ACHC) 2016 Q1 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • We are about to begin. As a reminder, this call is being recorded. Please proceed.

    我們即將開始。提醒各位,本次電話會議將被錄音。請開始。

  • - President

    - President

  • Good morning. I'm Brent Turner, President of Acadia Healthcare, and I'd like to welcome you to our first-quarter 2016 conference call. To the extent any non-GAAP financial measure is discussed in today's call, you will also find reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under our Investor's link.

    各位早安。我是 Acadia Healthcare 總裁 Brent Turner,歡迎各位參加我們 2016 年第一季電話會議。若今日電話會議中討論任何非 GAAP 財務衡量指標,您亦可在我們網站的投資人連結中,查看昨日新聞稿所提供之該衡量指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。

  • This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2016 and beyond. For this purpose any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements.

    本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義之前瞻性陳述,包括但不限於關於 Acadia 對 2016 年及其後預期之季度與年度財務表現的陳述。就此而言,本次電話會議中任何非歷史事實之陳述,均可能被視為前瞻性陳述。

  • Without limiting the foregoing, the words believes, anticipates, plans, expects, and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the Company's first-quarter news release.

    在不限制前述內容之前提下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在識別前瞻性陳述。特此提醒您,這些陳述可能受到多項重要因素影響(包括但不限於)Acadia 向美國證券交易委員會提交之文件以及本公司第一季新聞稿中所載之因素。

  • And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

    因此,實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。本公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。

  • At this time for opening remarks I'd like to now turn the conference over to our Chairman and Chief Executive Officer, Joey Jacobs.

    現在進入開場致詞,我想將電話會議交給我們的董事長兼執行長 Joey Jacobs。

  • - Chairman and CEO

    - Chairman and CEO

  • Good morning and welcome to our first-quarter conference call. In addition to Brent I'm here today with Chief Financial Officer David Duckworth and other members of our Executive Management Team.

    各位早安,歡迎參加我們的第一季電話會議。除 Brent 之外,今天與我一同出席的還有財務長 David Duckworth 以及我們執行管理團隊的其他成員。

  • David and I each have some brief remarks about the first quarter and our outlook for Acadia. Then we'll open the line for your questions.

    David 和我將分別就第一季表現及 Acadia 的展望做一些簡短說明。之後我們將開放提問。

  • As our first-quarter results make clear, Acadia has continued to produce strong profitable growth through outstanding and disciplined execution of our long-term organic and acquisition growth strategies. Our revenue for the quarter increased 68.6%, and our adjusted net income from continuing operations attributable to Acadia's stockholders increased 69.1%.

    從我們第一季的結果可清楚看出,Acadia 透過對長期內生成長與併購成長策略的卓越且嚴謹的執行,持續創造強勁且具獲利性的成長。本季營收成長 68.6%,而歸屬於 Acadia 股東之持續營運調整後淨利成長 69.1%。

  • Our adjusted diluted EPS grew 27.9%, which includes the impact of new shares of common stock issued primarily related to acquisitions. In addition to the strength of this financial performance, the headline news for the first quarter was our acquisition of the Priory Group in the UK, which we discussed in depth in our fourth-quarter conference call.

    我們的調整後稀釋每股盈餘(EPS)成長 27.9%,其中包含主要與併購相關而新發行普通股所帶來的影響。除財務表現強勁之外,第一季的重點消息是我們在英國收購 Priory Group;我們已在第四季電話會議中深入討論此案。

  • We want to update you on the review of the Priory transaction by the Competition and Markets Authority, or CMA. We are working through the merger review process, and expect to submit our formal notification to the CMA in early May. With an early May submission we expect the CMA to complete its review in late June. The Priory transaction provides us a significant tailwind and visibility into achieving continued substantial profitable growth for 2016.

    我們希望向各位更新競爭與市場管理局(Competition and Markets Authority,簡稱 CMA)對 Priory 交易的審查進度。我們正依併購審查流程推進,並預期於 5 月初向 CMA 提交正式申報。若於 5 月初提交,我們預期 CMA 將於 6 月下旬完成審查。Priory 交易為我們帶來顯著助力,並提升我們在 2016 年達成持續且可觀之獲利成長的能見度。

  • We completed 2015 with approximately 9,900 beds. The Priory transaction alone adds approximately 7,100 beds, and the largest acquisition we have completed. Acadia now has approximately 17,400 total beds.

    我們在 2015 年底約有 9,900 張床位。僅 Priory 交易就新增約 7,100 張床位,且為我們完成過的最大宗收購案。Acadia 目前合計約有 17,400 張床位。

  • Our organic growth strategy also produced excellent results for the first quarter, with consolidated same-facility revenue growth of 9.2%. Much of this growth was the result of beds added to our same-facility base in the last 12 months. These same-facility beds were a portion of the total of 850 beds we added over the past 12 months to our existing facilities and through two de novo facilities. We added 330 beds during the first quarter of 2016.

    我們的內生成長策略在第一季亦取得優異成果,合併同店營收成長 9.2%。此成長多數來自於過去 12 個月內加入同店基礎的新增床位。這些同店床位屬於我們在過去 12 個月於既有設施及兩家新設(de novo)設施中合計新增 850 張床位的一部分。我們在 2016 年第一季新增 330 張床位。

  • In summary, we are very pleased with Acadia's performance for the first quarter, we believe strong execution of our business model has positioned us well in a nearly $50 billion industry with growing market demand and limited excess capacity. We are very diversified with regard to our business lines, our payers, and our geographic footprint.

    總結而言,我們對 Acadia 第一季的表現非常滿意;我們相信,對商業模式的強勁執行使我們在一個近 500 億美元、需求成長且過剩產能有限的產業中具備良好定位。就業務線、付款方以及地理布局而言,我們的多元化程度很高。

  • We are continuing to invest in capacity to meet increasing demand organically, even as we strengthen our ability to complete these projects routinely. In a highly fragmented market we also have the experience, and we believe Priory demonstrates the access to capital to continue executing one of the industry's most successful records of completing and integrating acquisitions. As a result, we remain confident of our prospects for future growth and earnings in shareholder value.

    我們持續投資產能以有機方式滿足日益增加的需求,同時也強化我們例行完成這些專案的能力。在高度分散的市場中,我們亦具備相關經驗;且我們相信 Priory 展現了我們取得資本的能力,得以持續締造業界最成功之一的併購完成與整合紀錄。因此,我們對未來成長與獲利以及股東價值的前景仍充滿信心。

  • Thank you for your interest in Acadia, and now here's David Duckworth.

    感謝各位對 Acadia 的關注,接下來請 David Duckworth 發言。

  • - CFO

    - CFO

  • Thanks, Joey, and good morning. Acadia's revenue for the first quarter of 2016 increased 68.6% to $616.8 million from $365.8 million for the first quarter of 2015. Adjusted income from continuing operations attributable to Acadia stockholders was $45.8 million, up 69.1% from $27.1 million.

    謝謝你,Joey,各位早安。Acadia 2016 年第一季營收較 2015 年第一季的 3.658 億美元成長 68.6%,至 6.168 億美元。歸屬於 Acadia 股東之持續營運調整後淨利為 4,580 萬美元,較 2,710 萬美元成長 69.1%。

  • Adjusted EPS for the first quarter of 2016 was $0.55, up 27.9% from $0.43 for the first quarter of 2015. For the first quarter of 2016 our adjusted EPS excludes transaction-related expenses of $26.3 million and a gain on foreign currency derivatives of approximately $400,000.

    2016 年第一季調整後每股盈餘為 0.55 美元,較 2015 年第一季的 0.43 美元成長 27.9%。2016 年第一季的調整後 EPS 排除 2,630 萬美元的交易相關費用,以及約 40 萬美元的外匯衍生性金融工具收益。

  • For the first quarter of 2015, adjusted EPS excludes transaction-related expenses of $18.4 million and a small gain on foreign currency derivatives. Rated average diluted shares outstanding increased 33.1% for the comparable quarters, primarily due to the equity that we issued in February and May of 2015 that was principally related to acquisitions and in January and February of 2016 related to the acquisition of Priory.

    2015 年第一季的調整後 EPS 排除 1,840 萬美元的交易相關費用,以及一筆小額的外匯衍生性金融工具收益。就可比季度而言,加權平均稀釋流通在外股數增加 33.1%,主要係因我們於 2015 年 2 月與 5 月發行的股權(主要與併購相關),以及於 2016 年 1 月與 2 月為收購 Priory 而發行的股權。

  • Acadia's tax rate on adjusted income from continuing operations before income taxes was 21.9% for the first quarter of 2016, compared with 31.5% for the first quarter last year. Acadia's same-facility revenue increased 9.2% from the first quarter of 2015, with an 8.6% increase in patient days and a 0.5% increase in revenue-per-patient day.

    Acadia 2016 年第一季持續營運之調整後稅前所得適用稅率為 21.9%,相較去年第一季為 31.5%。Acadia 同店營收較 2015 年第一季成長 9.2%,其中病患日數增加 8.6%,每病患日營收增加 0.5%。

  • Same-facility EBITDA margin was 27.1% for the latest quarter, versus 26.3% for the first quarter of 2015. Adjusted consolidated EBITDA increased 66.4% to $131 million, which was 21.2% of consolidated revenue from $78.7 million, or 21.5% of consolidated revenue for the first quarter of 2015.

    最新季度同店 EBITDA 利潤率為 27.1%,相較 2015 年第一季為 26.3%。調整後合併 EBITDA 成長 66.4% 至 1.31 億美元,占合併營收 21.2%;2015 年第一季為 7,870 萬美元,占合併營收 21.5%。

  • Our operating cash flow increased to $59.3 million in the first quarter from $18.1 million in the first quarter of 2015. Our adjusted operating cash flow for the quarter was $86.2 million when you adjust for the cash transaction-related expenses paid during the first quarter.

    我們第一季營運現金流量由 2015 年第一季的 1,810 萬美元增加至 5,930 萬美元。若將第一季支付的現金交易相關費用加回調整,本季調整後營運現金流量為 8,620 萬美元。

  • Finally, as announced in yesterday's news release, we have affirmed our established 2016 guidance, including adjusted earnings per diluted share, in a range of $2.81 to $2.86, which is an increase of 26% to 28% over 2015. Our financial guidance excludes the impact from any future acquisitions and transaction-related expenses.

    最後,如同昨日新聞稿所宣布,我們已確認既定的 2016 年財測指引,包括調整後稀釋每股盈餘,區間為 2.81 美元至 2.86 美元,較 2015 年成長 26% 至 28%。我們的財務指引不包含任何未來併購及交易相關費用的影響。

  • This concludes our prepared remarks this morning, and thank you for being with us. I will now ask Yolanda to open the floor for your questions.

    以上為我們今天上午的預先準備發言,感謝各位與會。接下來我將請 Yolanda 開放提問。

  • Operator

    Operator

  • Certainly.

    當然。

  • (Operator Instructions)

    (接線員指示)

  • AJ Rice, UBS.

    AJ Rice,瑞銀(UBS)。

  • - Analyst

    - Analyst

  • Thanks.

    謝謝。

  • I was going to just maybe ask about the relief on the IMD exclusion that was included in the Medicare -- Medicaid managed care rule. Can you just tell us about how much needs to be done in terms of contracting with payers, and in terms of your discussions with referral sources to get this thing in place so that you're actually deriving some benefit from it?

    我想問一下,關於 Medicare—Medicaid 管理式照護規則中所納入的 IMD 排除條款放寬。你們能否說明,為了讓這項措施真正落地並實際帶來效益,在與付款方簽約方面還需要做多少工作,以及在與轉介來源的討論方面需要做哪些事情?

  • - Chairman and CEO

    - Chairman and CEO

  • Thanks, AJ, this is Joey.

    謝謝你,AJ,我是 Joey。

  • We are very excited about this regulation change and are looking forward to July of this year when it will begin. We are probably 90% -- we probably already have contracts with managed Medicaid in probably 90% of all of our facilities with the managed Medicaid payers there. There are a few that we will be contacting and working with, so we're already in a good position there.

    我們對這項法規變更感到非常振奮,並期待今年 7 月開始生效。我們大概已在約 90% 的機構與當地的管理式 Medicaid 付款方簽有合約。仍有少數我們會去聯繫並合作處理,所以目前我們已處於相當有利的位置。

  • We will be, over the next 60 days, redoubling our efforts to just let the referral sources know that the adult Medicaid patient can now be treated at a freestanding psych hospital, and our facilities are busy getting that done too. So we think we're going to be in good position as of July 2016.

    接下來 60 天內,我們會加倍努力,讓轉介來源了解:成人 Medicaid 病患現在可以在獨立式精神科醫院接受治療;我們的各院所也正積極推動完成這件事。因此我們認為到 2016 年 7 月時,我們會處於很好的位置。

  • Our occupancy for the Company right now is about 79% to 80%. So we have about 20% unused capacity. And the reason for that is that we did add 330 beds during the first quarter. So we think we're in a good position to enter July 2016 for the IMD and hopefully be able to treat more of the Medicaid adult patients in our facilities.

    公司目前的入住率約為 79% 到 80%。因此我們約有 20% 的閒置產能。原因是我們在第一季新增了 330 張病床。所以我們認為在 2016 年 7 月 IMD 生效時,我們已準備就緒,並希望能在我們的機構中收治更多 Medicaid 成人病患。

  • So work to be done. We've already made great progress, so we're looking forward to getting to July 2016.

    所以仍有工作要做。我們已取得很大進展,也期待迎接 2016 年 7 月。

  • - Analyst

    - Analyst

  • Okay, and then maybe one follow up.

    好的,那我再追問一個。

  • So the merger review is going on, and you said you hope to be resolved in June. I know there are some things you've agreed not to consolidate until that review is complete, but you have a synergy target for this year. Can you tell us what can you do with Priory and what do you have pending until the deal gets done? And how is Priory going so far now that you have just a few months under your belt?

    併購審查正在進行中,你們說希望在 6 月解決。我知道在審查完成前,你們同意有些事情不進行整併,但你們今年有協同效益目標。你們能否說明:對 Priory 目前可以做哪些事、哪些要等交易完成後才能做?以及在你們接手幾個月後,Priory 目前進展如何?

  • - Chairman and CEO

    - Chairman and CEO

  • Sure. It has only been 45 days since we made that acquisition. Well, a little bit more than 45 days, 45 days in this result. Our operating team was over there two weeks ago, and Priory is off to a good start. The chemistry between them and us here is very, very good. They're very eager and excited about being a part of Acadia.

    當然。我們完成那項收購至今只有 45 天。嗯,略多於 45 天,這次結果反映的是 45 天。我們的營運團隊兩週前到那邊,Priory 開局良好。他們與我們之間的合作默契非常、非常好。他們非常渴望也很興奮能成為 Acadia 的一員。

  • We are working through the CMA process. We run the business as if we would run the business, any of our businesses in the Company and supporting them and giving them access to capital and reviewing operations. So that part is business as normal.

    我們正在推進 CMA 的流程。我們以經營公司任何業務的方式來經營該業務,提供支援、讓他們取得資本、並檢視營運。因此這部分一切如常運作。

  • What you can't do is we have -- we can't go after the synergies until we get through this process. So hopefully by the end of June we'll get through the process and then that will be the next actionable thing we will do with this transaction.

    但你不能做的是——我們在完成這個流程之前,不能去追求協同效益。所以希望在 6 月底前能完成流程,接著這將是我們在這筆交易上下一個可執行的重點。

  • - Analyst

    - Analyst

  • Okay, great. Thanks a lot

    好的,很棒。非常感謝。

  • Operator

    Operator

  • Kevin Fischbeck, Bank of America Merrill Lynch. Hearing no response from that line, we'll go next to Brian Tanquilut, Jefferies.

    Kevin Fischbeck,美國銀行美林。該線路沒有回應,我們接著請 Brian Tanquilut,Jefferies。

  • - Analyst

    - Analyst

  • This is Jason Plagman on for Brian.

    我是 Jason Plagman,代 Brian 發言。

  • Just another follow up on the IMD. How are you thinking about how that change affects the pace of your bed add over the next few years or your outlook for pace of bed adds?

    再追問一個關於 IMD 的問題。你們如何看待這項變更,對未來幾年你們新增病床的速度或新增病床步調展望會有什麼影響?

  • - Chairman and CEO

    - Chairman and CEO

  • I think you saw that with us getting 330 beds online in the first quarter. We're targeting another substantial number in the second quarter. So we have internally been aggressive on getting these beds built and getting them online. We didn't know when the regulation was going to be effective, but we're going to have these beds online by July 2016.

    我想你們已看到,我們在第一季讓 330 張病床上線。我們第二季也鎖定再新增相當可觀的數量。因此在內部,我們在建置並讓病床上線方面一直採取積極作法。我們先前並不知道法規何時生效,但我們會在 2016 年 7 月前讓這些病床上線。

  • So we're in a good position once again. We're at 80% occupancy, so for the next several months we can handle the additional incremental patients, and then we will see how the volume ramps up and builds. And if we need to build more beds for our facilities we can do that. And so we think we're in a good position about how we've built our beds, gotten ready for July, and we'll build additional beds as we see the volume come to us over the last six months of this year.

    所以我們再次處於很好的位置。我們的入住率為 80%,因此接下來幾個月我們可以承接額外的增量病患,之後再觀察量能如何爬升與建立。如果我們需要為院所再增建更多病床,我們也可以這麼做。因此我們認為,在病床建置、為 7 月做好準備方面我們處於良好位置;並且在今年下半年隨著量能到來,我們會視情況再增建病床。

  • - Analyst

    - Analyst

  • And just to follow up on that.

    再就此追問一下。

  • Do you think these new patients could get back to organic growth in the above double digits? Kind of lift that organic growth rate back in the 10% to 12% range or even higher?

    你認為這些新病患是否可能讓內生成長回到雙位數以上?例如把內生成長率拉回 10% 到 12% 區間,甚至更高?

  • - Chairman and CEO

    - Chairman and CEO

  • Well when you look at the US same facility we did 9.9%. That's pretty damn good. And so I am just very pleased with what Ron Fincher and his team are doing.

    嗯,當你看美國同院所(same facility)的表現,我們做到了 9.9%。這相當、相當不錯。所以我對 Ron Fincher 及其團隊的表現非常滿意。

  • And once again, we're going to be in the high single digits. And could you have a quarter where it might be in double digits? Sure. But we're not planning on that. We're just planning on similar results as what we had in the first quarter of this year.

    再說一次,我們預期會維持在高個位數。你是否可能有某一季達到雙位數?當然。但我們並未以此作為規劃。我們只是規劃能有與今年第一季相近的結果。

  • - Analyst

    - Analyst

  • Okay. That's helpful.

    好的。這很有幫助。

  • And then one other quick follow up, or a different topic. On M&A how should be thinking about the pipeline in the US and the pace and sequencing of how deals might come in over the next 12 months or so?

    另外再快速追問一個,或換個主題。關於併購(M&A),我們應如何看待美國的案源管線,以及未來約 12 個月交易可能進來的速度與先後順序?

  • - Chairman and CEO

    - Chairman and CEO

  • The pipeline is very busy. We will make single facility transactions, acquisitions, throughout the remainder of this year. We are focused on the US markets and have lots of opportunities there.

    案源管線非常活躍。在今年剩餘期間,我們會持續進行單一院所的交易與收購。我們聚焦於美國市場,且那裡有很多機會。

  • And Steve Davidson is very busy and he's keeping me very busy on the road going out and looking at acquisitions. So the pipeline looks good, and we will make some single acquisitions throughout the remainder of this year.

    而 Steve Davidson 非常忙,也讓我在路上非常忙,外出看各種收購案。所以案源看起來不錯,我們在今年剩餘期間會完成一些單一院所的收購。

  • - Analyst

    - Analyst

  • Great. Thanks.

    很好。謝謝。

  • Operator

    Operator

  • Kevin Fischbeck, Bank of America Merrill Lynch.

    Kevin Fischbeck,美國銀行美林。

  • - Analyst

    - Analyst

  • Sorry about that. Technical difficulties.

    抱歉。技術問題。

  • - Chairman and CEO

    - Chairman and CEO

  • Kevin, you only get one question because you dropped off. (laughter)

    Kevin,你因為掉線了,所以只能問一個問題。(笑聲)

  • - Analyst

    - Analyst

  • I got to make it count then. One of your biggest competitors was talking about how there were shortages of psychiatrists and other clinical staff.

    那我得讓它有份量。你們最大的競爭對手之一提到精神科醫師以及其他臨床人員短缺。

  • It doesn't seem like you are seeing it, but just wanted to get your sense of that and to the extent that there are markets where that's an issue. How do you manage that transition of IMD, excluding going away and the potential demand that's going to maybe put pressure on that labor supply?

    看起來你們似乎沒有遇到,但我想了解你們的看法,以及在哪些市場這會成為問題的程度。在 IMD 排除條款逐步取消、以及可能增加的需求或許會對勞動供給造成壓力的情況下,你們如何管理這個轉換?

  • - Chairman and CEO

    - Chairman and CEO

  • We think we're in a very good position with our psychiatrists. Once again Ron Fincher was ahead of this curve, and we've already had a position recruitment department. But probably 24 months ago we made a substantial investment in that department, and they've been very, very successful. So right now we're not seeing that impact to our patient day growth.

    我們認為在精神科醫師配置方面,我們處於非常有利的位置。再一次,Ron Fincher 早就預見了這個趨勢,我們也早已有專責的招募部門。但大約在 24 個月前,我們對該部門做了相當大的投資,而他們非常、非常成功。因此目前我們沒有看到這對我們的病人日(patient day)成長造成影響。

  • We grew 8% here in the US in the first quarter. So always, you can always use more psychiatrists, but Ron has a plan to recruit those and right now it's not hurting us.

    我們在美國第一季成長了 8%。所以當然,精神科醫師永遠是越多越好,但 Ron 有招募計畫,而目前這並沒有傷害到我們。

  • - Analyst

    - Analyst

  • You mentioned that on the contracting side you're 90% of the way there, but you have to talk to the referral sources just to get them to understand that you can take these patients. A lot of these referral sources have built out beds and capacity to treat these patients because they basically had to because there was no other place for them. In these conversations with the referral sources, how willing do they appear to be to just let that business move out, and how -- or conversely how ingrained is that part of their business and do they want to keep it?

    你提到在簽約端你們已完成 90%,但還需要和轉介來源溝通,讓他們理解你們可以收治這些病人。許多轉介來源因為基本上別無選擇,只好自行擴建病床與容量來治療這些病人。在與轉介來源的對話中,他們看起來有多願意讓這塊業務移出?或者反過來說,這在他們的業務中有多根深蒂固、他們是否想保留?

  • - Chairman and CEO

    - Chairman and CEO

  • It's not ingrained at all, and quite frankly med-surg hospitals do not like having psychiatric services in their facilities. They're more high tech oriented, procedure oriented, which is great. That's what they do the best.

    一點也不根深蒂固;坦白說,內外科(med-surg)醫院並不喜歡在院內提供精神科服務。他們更偏向高科技、以手術/處置為導向,這很好。那是他們最擅長的。

  • And as we see with our joint venture opportunities, more and more of these large not-for-profit systems quite frankly want to get out of it and give it to us and just take a minority position in our facilities so that they have access to the care. So there's roughly I think, last time I looked, I think there's 1,200 units inside 5,000 med-surg hospitals, and that's declined from 1,500 when PPS was entered into.

    而且從我們看到的合資機會來看,越來越多大型非營利體系坦白說想退出,交給我們來做,自己只在我們的機構持有少數股權,以確保能取得照護資源。所以大約——我記得上次看——大概有 1,200 個單位在 5,000 家內外科醫院裡,而這個數字已從 PPS 上路時的 1,500 下降。

  • So we still think more will close. There will be a few that will add, but the med-surg hospitals once again, they're procedure, high tech-oriented, and they just want access to the service.

    所以我們仍認為還會有更多關閉。會有少數增加,但內外科醫院再次強調是以處置、高科技為導向,他們只是想要能取得這項服務。

  • We are opening up our joint venture in the Memphis market. It opens up in May. So that one will be coming online. So we're partnering there with the big Baptist health system, and so we're very -- we do not see that as an issue.

    我們正在孟菲斯市場開設合資案。將於 5 月開幕。所以那個案子會開始上線營運。我們在那裡與大型的 Baptist 健康體系合作,因此我們非常——我們不認為這會是個問題。

  • - Analyst

    - Analyst

  • Okay, and then maybe last question about that. These conversations we've often heard come through two joint ventures and things like that with nonprofits, that it often takes a year or two to get the hospitals to decide this is what we want to do, we do want to partner, this is where we're going.

    好的,那也許最後一個相關問題。我們常聽到,透過與非營利機構的合資等方式,醫院往往需要一到兩年才會決定「這就是我們想做的,我們確實想合作,我們要往這個方向走」。

  • Is that the way to think about this, the benefit from IMD, that it takes that long to get the hospital to change? Or do you think it will be something faster than that?

    對 IMD 的效益也應該這樣理解嗎——也就是需要那麼久醫院才會改變?還是你認為會更快?

  • - Chairman and CEO

    - Chairman and CEO

  • I think that's about right. I think what you'll see is we've built up our inventory. And I think starting in 2017, you could see us do four to six a year because of the activity we have on the pipeline.

    我認為差不多就是這樣。我想你會看到我們已經建立起我們的案源庫存(inventory)。而且我認為從 2017 年開始,基於我們管線上的活動量,你可能會看到我們一年做 4 到 6 個。

  • And we're close to announcing another one in the next 30 days. So we have a lot of activity.

    而且我們很接近在未來 30 天內宣布另一個案子。所以我們有很多進展。

  • Steve and I are going -- making a trip next week to a large system that called us and said hey, we want you to come down and talk about doing it for us. So the word is getting out there that we do this, and so we're getting inbound calls from the systems.

    Steve 和我下週要——要去拜訪一個大型體系;他們打電話給我們說,嘿,我們希望你們過來談談,替我們做這件事。所以市場上已經開始知道我們在做這個,因此我們正收到來自各體系的主動來電。

  • - Analyst

    - Analyst

  • All right great. Thanks.

    好,很好。謝謝。

  • Operator

    Operator

  • Paula Torch, Avondale Partners.

    Paula Torch,Avondale Partners。

  • - Analyst

    - Analyst

  • Thank you, good morning. So on the same IMD subject, how should we think of the exclusion opportunity on the substance abuse side?

    謝謝,早安。同樣在 IMD 這個主題上,我們應該如何看待在物質濫用(substance abuse)端的排除條款機會?

  • Just wondering maybe how many of your CRC facilities right now could take managed Medicaid patients, or do you think you'd be acquiring or building out more beds specific to that population? And then just as a follow up to that, what is the CTC opportunity, and does this change the potential there, as well?

    想請教目前你們有多少 CRC 機構可以收治受管理式 Medicaid(managed Medicaid)涵蓋的病人?或者你認為你們會為該族群收購或新建更多病床?另外追問一下,CTC 的機會是什麼?這是否也會改變那邊的潛力?

  • - Chairman and CEO

    - Chairman and CEO

  • Okay, the first one, the CTC does not change the opportunity there. The opportunity there was already great to begin with. So it doesn't impact really the CTC part.

    好的,第一個,CTC 不會改變那邊的機會。那邊的機會本來就已經很大。所以它其實不影響 CTC 的部分。

  • On our recovery division for substance abuse, it varies. Most of our businesses were not in the Medicaid adult business, but we do have a few states where we are dominant in that business and we are building more beds for them and expanding our services for them.

    至於我們的物質濫用復元事業部,情況不一。我們大多數業務並不在 Medicaid 成人市場,但在少數幾個州,我們在那塊業務中占有主導地位,我們也正在為他們增建更多病床並擴大服務。

  • So where we have a presence and are taking care of that population, we are expanding. And then on the other ones, if the CEO came to us and said there's an opportunity here we would look at it and absolutely if we have the capital to do that.

    所以在我們有據點、且正在照護該族群的地方,我們正在擴張。至於其他地方,如果執行長來找我們說這裡有機會,我們會評估;而且只要我們有資本可以投入,當然會做。

  • But right now we have a few states where we're, I would say, dominant in that business. So we will continue to support them and expand their services.

    但目前我們在少數幾個州——我會說——在那塊業務是主導者。所以我們會持續支持他們並擴大他們的服務。

  • - Analyst

    - Analyst

  • Okay. And then if we could stay on the recovery division for one more second, just wondering what the occupancy rate is there for those particular beds. I know that it's been improving. And wonder, you had talked previously about additional synergies in 2016, and just would like you to remind us of what that number is.

    好的。那如果我們在復元事業部再停留一下,想請教那些特定病床的入住率是多少。我知道它一直在改善。另外,你之前談到 2016 年會有額外的綜效,想請你提醒我們那個數字是多少。

  • - Chairman and CEO

    - Chairman and CEO

  • Okay.

    好的。

  • On the occupants, I do not have the individual occupancy by product line with me, Paula, so I can't give you that number. I will say this, that one of our facilities, it's been since 2010 since we've had a quarter as good as the one they had in the first quarter of 2016. So it's been six years.

    關於入住率(occupancy),Paula,我手邊沒有按產品線拆分的個別入住率,所以我無法給你那個數字。但我可以說的是,我們其中一家機構,自 2010 年以來,從未有任何一季像 2016 年第一季那麼好。也就是說,已經六年了。

  • So our -- Joe Procopio and what he's doing in that division is working. So I don't have the occupancy here with me, but we are filling up the beds and have good results there. And as far as the other, Brent?

    所以我們——Joe Procopio 以及他在那個事業部所做的事情正在奏效。我手邊沒有入住率,但我們正在把病床填滿,而且那邊的成果很好。至於另一個問題,Brent?

  • - President

    - President

  • This is Brent. On the synergies related to the CRC transaction, as you might recall we had indicated that our expectation was to get $10 million of synergy benefit in the first year ramping up to a total of $15 million by the end of the second year.

    我是Brent。關於與CRC交易相關的綜效,如各位可能記得,我們曾表示預期第一年可取得1,000萬美元的綜效效益,並在第二年年底提升至合計1,500萬美元。

  • And we were on pace with the first year, and absolutely on pace to realize that by the end of the second year in total. So very consistent execution from the integration of the business as we had expected a year and a half ago when we made that acquisition.

    而我們第一年的進度符合預期,也完全按進度在第二年年底前實現合計目標。因此,業務整合的執行非常一致,符合我們在一年半前進行該收購時的預期。

  • - Analyst

    - Analyst

  • Okay, great. And then just one last one for me on the UK business. I know that you're still ramping a number of de novos that you've been investing in and acquisitions that you've made in the UK. So just curious where we are in the cycle and when do you expect those investments to be accretive? As I believe it takes a little bit longer for those to ramp, so just wondering where we are on that.

    好的,很棒。接著我最後一個問題是關於英國業務。我知道你們仍在加速推進一些你們投入資金的新設據點(de novos)以及在英國完成的收購案。所以我想了解我們目前處於週期的哪個階段,以及你們預期這些投資何時開始具增益(accretive)?我相信這些需要更長時間爬坡,因此想請教目前的進展。

  • Thank you.

    謝謝。

  • - Chairman and CEO

    - Chairman and CEO

  • Well the de novos, we're hopeful to have them breaking even in the first 12 months, and then the accretion starts thereafter. And ramping them up and getting them closer to the margin for our same facilities. So that's what's going on, and that's what the expectation is in the UK.

    關於新設據點,我們希望在前12個月達到損益兩平,之後才開始帶來增益。並逐步拉升營運,使其利潤率更接近我們既有設施的水準。這就是目前的狀況,也是我們對英國的預期。

  • And we have invested money there to expand their facilities and to meet the continuum of care over there. Both teams, whether it's PIC or Priory, are working very hard on filling the beds and growing the census.

    此外,我們也在那邊投入資金以擴建其設施,並滿足當地的連續照護(continuum of care)需求。兩個團隊,不論是PIC或Priory,都非常努力在提升床位入住並增加在院人數(census)。

  • - Analyst

    - Analyst

  • Thank you.

    謝謝。

  • Operator

    Operator

  • Chris Rigg, Susquehanna Financial Group.

    Chris Rigg,Susquehanna Financial Group。

  • - Analyst

    - Analyst

  • Just wanted to come back to IMD real quickly. Obviously we've got the Medicaid managed care component to it.

    我想很快再回到IMD的議題。顯然其中包含了Medicaid管理式照護(managed care)的部分。

  • I was wondering if you have done any work to figure out the population that's still in fee-for-service versus what's in managed care? And really asking do you still need legislation to really see a massive increase, or is it this good enough just on the Medicaid managed care side? Thanks.

    我想請問你們是否做過任何分析,以了解仍在按服務計費(fee-for-service)的人口占比,與已納入管理式照護的人口占比?我真正想問的是:要看到大幅增加是否仍需要立法,或僅靠Medicaid管理式照護這一端就已足夠?謝謝。

  • - Chairman and CEO

    - Chairman and CEO

  • The country needs the IMD to go away. So that -- for that 25% that's out there in the traditional Medicaid product, that they can come to a freestanding hospital.

    全國都需要讓IMD限制取消。如此一來,仍在傳統Medicaid產品中的那25%人群,才能到獨立精神專科醫院(freestanding hospital)就醫。

  • I was in Washington DC two weeks ago working on this issue. And we're not getting any pushback from Washington on this issue. But it is, as you know, it's an election year and it's a little tougher now.

    我兩週前在華盛頓特區就這個議題進行推動。而我們並未從華府在此議題上收到任何反對聲音。但如你所知,今年是選舉年,現在推動起來會比較困難一些。

  • And so we need that and the country needs that. We will get a benefit from this Medicaid change in the regulations for the managed Medicaid. And that is a good thing, a good step. But obviously if you can get the other 25% roughly being able to come to us, that would be significant.

    因此我們需要這項改變,國家也需要。我們會因這次針對管理式Medicaid的法規變更而受益。這是好事,也是正向的一步。但顯然,如果能讓另外約25%的人也能來我們這裡,那將會非常顯著。

  • So we want that also. This is what we do. This is all we do, and those patients really need access to other providers and especially the freestanding providers.

    所以我們也希望能做到這點。這就是我們的專長。我們只做這件事,而那些病患確實需要能接觸到其他提供者,尤其是獨立型提供者(freestanding providers)。

  • - Analyst

    - Analyst

  • Great.

    很好。

  • And then just on the Priory synergies, can you give us an update in terms of what's expected in 2016 versus what's expected to roll into 2017?

    另外關於Priory的綜效,你能否更新一下:2016年預期是多少,以及預期會有多少延續到2017年?

  • - Chairman and CEO

    - Chairman and CEO

  • I won't give you any specific numbers. We have said that there is -- we think there's $20 million out there. We will try to get it as quickly as possible and do the right thing.

    我不會提供任何具體數字。我們曾說過,我們認為大約有2,000萬美元的空間。我們會盡可能快地取得,同時把事情做對。

  • So I think as we stated when we did the Priory transaction, we've given ourselves two years to get that done. I think it will be faster than that. But once again we've got to get it through the CMA process and get that behind us before we can really work on this issue.

    因此我想,如同我們在進行Priory交易時所說,我們給自己兩年的時間完成。我認為會比這更快。但再一次,我們必須先走完CMA流程並把這件事處理完,之後才能真正著手推進這個議題。

  • - Analyst

    - Analyst

  • Okay, great. Thanks a lot.

    好的,很棒。非常感謝。

  • Operator

    Operator

  • Frank Morgan, Royal Bank of Canada Capital Markets.

    Frank Morgan,加拿大皇家銀行資本市場(RBC Capital Markets)。

  • - Analyst

    - Analyst

  • To follow up on this question, as we think about the balance of the year given what's going on with this CMA review and the ramp up, is there any reason or any thoughts we should have around the cadence of guidance over the rest of the year? I know you're reaffirming your annual guidance, but is there anything as you look out at the street right now when you look at that cadence, any inputs or suggestions you might give us there?

    延續這個問題,考量到今年剩餘期間在CMA審查與爬坡(ramp up)方面的進展,對於全年剩餘時間的財測節奏(cadence of guidance),是否有任何原因或想法需要我們留意?我知道你們重申全年指引,但就你們目前對市場(street)預期的觀察,在節奏上是否有任何輸入或建議可以提供?

  • - Chairman and CEO

    - Chairman and CEO

  • Frank, as we work through these issues if it's appropriate to raise our guidance or to revise our guidance, we're going to do that. And so -- and the revision to me would be to the upside is how I'm seeing the future.

    Frank,當我們處理這些議題時,如果適合上調指引或修正指引,我們就會這麼做。而我所理解的「修正」會是往上調,這是我對未來的看法。

  • So we just got to get through these things. We've got to get IMD in place, we've just got a get through the CMA process, and just see how the third quarter goes. And if at the end of the third quarter if we need to raise guidance we will do that, but we just got a get to that quarter. But if it's positive and significantly positive, as we've done in the past we'll raise our guidance.

    所以我們只需要把這些事情走完。我們必須讓IMD到位,也必須走完CMA流程,並看看第三季的表現。如果在第三季結束時我們需要上調指引,我們會這麼做,但我們得先走到那個季度。不過如果結果是正向且顯著正向,如同我們過去所做的,我們會上調指引。

  • - Analyst

    - Analyst

  • Okay. But in terms of just the quarters coming up for second, third, fourth is there any reason why we should think about redistributing it based on your assumption?

    好的。但就接下來第二、第三、第四季而言,是否有任何原因讓我們認為在你們假設下,應該重新分配(redistribute)這個節奏?

  • - Chairman and CEO

    - Chairman and CEO

  • No.

    沒有。

  • - Analyst

    - Analyst

  • Okay, so cadence is fine.

    好的,所以節奏沒問題。

  • And then secondly, on that IMD population any color around what kind of rate you might get on that business compared to your other per diems, either for commercial or for Medicare? Thanks.

    第二個問題,關於那個IMD族群,在費率方面能否提供一些說明:相較於你們其他的每日費用(per diems),不論是商業保險或Medicare,大概會是什麼水準?謝謝。

  • - Chairman and CEO

    - Chairman and CEO

  • We expect the Medicaid rates to be the rates we have in our current contracts. So we'll just have to wait and see.

    我們預期Medicaid費率會是我們現有合約中的費率。所以我們只能再觀察看看。

  • No one has approached us about anything different. So we think the rates that we have in our current contracts, which we think 90% of those we have covered, so we're expecting the rates to be in that ballpark.

    目前沒有人來找我們談任何不同的條件。因此我們認為會是現有合約中的費率;我們認為其中90%已涵蓋,所以我們預期費率會落在那個區間。

  • - Analyst

    - Analyst

  • Okay. And in terms of just the absolute dollar, would be around let's say Medicare rates are, or would it be less, more, or about the same?

    好的。那以絕對金額來看,會大概接近Medicare費率嗎?還是會更低、更高,或差不多?

  • - Chairman and CEO

    - Chairman and CEO

  • It varies. It varies by state, Frank. And it varies by managed Medicaid plans. And so all of our per diems are close, especially on the acute services, the acute hospital which this would be covering. All of our rates are very close, so they would be similar to what we're getting for Medicare and the commercial payers.

    這會有差異。Frank,會因州而異。也會因管理式Medicaid計畫而異。因此我們所有的每日費用都相當接近,尤其是在急性服務、也就是急性醫院服務(這項政策涵蓋的範圍)。我們所有費率都非常接近,所以會與我們從Medicare與商業支付方取得的費率相近。

  • - Analyst

    - Analyst

  • Got you. And then just one final question. When I look at your cash flow generation and your balance sheet, obviously, given the fact you've got such a strong growth story, do you think you'll getting to a point where you can basically start to sell fund growth without really having to go back and access the capital markets?

    了解。最後一個問題。當我看你們的現金流創造能力與資產負債表,顯然,鑑於你們有很強的成長故事,你是否認為你們會到達一個階段,基本上可以用自有資金支持成長,而不必再回到資本市場籌資?

  • I think you said a couple months ago at our conference that there might be another portfolio opportunity coming around next year. Just any update on that.

    我記得你在幾個月前我們的會議上提到,明年可能還會有另一個投資組合的機會出現。想請問這方面有沒有任何最新進展。

  • Thanks.

    謝謝。

  • - Chairman and CEO

    - Chairman and CEO

  • We are already at the point where we can use our revolver and our cash that we're generating to do the one-off transactions. So we're already at that point. So then the large transaction that we talked about, it is going to be actionable, and so we'll just wait and see on the timing.

    我們現在已經到了可以動用循環信貸額度(revolver)以及我們所產生的現金,來進行一次性的交易。所以我們已經在那個階段了。至於我們談到的那筆大型交易,它將會是可執行的,我們就再觀察時點。

  • - Analyst

    - Analyst

  • Okay. Thank you.

    好的。謝謝你。

  • Operator

    Operator

  • Ana Gupte, Leerink Partners.

    Ana Gupte,Leerink Partners。

  • - Analyst

    - Analyst

  • Back to the UK, on the rate environment I think you had said that there was a rate update on April 1 from the NHS. It looked like the revenue per patient saw some pressure. I'm just wondering how that all played out and what the rate outlook was looking like for you?

    回到英國,關於費率環境,我記得你提到 NHS 在 4 月 1 日有一次費率更新。看起來每位病患的收入有些壓力。我想了解這整體情況最後是如何發展的,以及你們對費率前景的看法?

  • - Chairman and CEO

    - Chairman and CEO

  • Okay. There's two parts to this answer. One is what you see in the stats is just the mix of the patients, and we did consciously add beds at the lower revenue per day in a continuum of care. And so that impacted that.

    好的。這個答案有兩個部分。第一,你在統計數據中看到的其實只是病患組合的變化,而我們確實有意識地在照護連續體中增加了每床日收入較低的床位。因此那就造成了影響。

  • The rate negotiations are still going on. They will be effective April 1; it is a positive. And hopefully in the next 30, 60 days those negotiations will be completed, and once again they are retro back to April 1.

    費率談判仍在進行中。它們將自 4 月 1 日起生效;這是正面的。希望在接下來 30 到 60 天內談判能完成,而且同樣地會追溯回 4 月 1 日。

  • - Analyst

    - Analyst

  • So currently what you reported doesn't have that update?

    所以你們目前所報告的數字還沒有包含那次更新?

  • - Chairman and CEO

    - Chairman and CEO

  • Right.

    對。

  • - Analyst

    - Analyst

  • On these, and pardon me for my lack of knowledge about the regulatory environment in the UK, but to the extent that the NHS is outsourcing to private payers do they have any influence on how the CMA would view the Priory transaction and then try to speed that up in terms of letting you integrate the acquisition?

    關於這點,也請原諒我對英國監管環境不夠了解,但就 NHS 將業務外包給民營機構的程度而言,他們是否會影響 CMA 對 Priory 交易的看法,並在允許你們整合收購方面加快進度?

  • - Chairman and CEO

    - Chairman and CEO

  • Obviously it's a government agency and I assume they talk to each other. I think the CMA has their process and their timeline and their procedures, and that's where we're at and that's how it will go. That this is governed by the CMA timeline and procedures.

    顯然它是政府機構,我想他們彼此之間會有溝通。我認為 CMA 有其流程、時程與程序;我們目前就是在那個階段,也會照那樣進行。這件事是由 CMA 的時程與程序所主導。

  • - Analyst

    - Analyst

  • Okay. And then the final question, what do you have in guidance as far as currency risk? There was all this discussion about Brexit, and what is in there.

    好的。最後一個問題,你們在財測指引中對匯率風險的假設是什麼?大家一直在討論英國脫歐,指引裡面包含了哪些假設?

  • - Chairman and CEO

    - Chairman and CEO

  • So, Ana, we've got -- we've estimated our UK business will translate over at GBP1.45 to $1 ratio. Obviously our first quarter, the FX rate was below that but you didn't see any material impact on our business.

    Ana,我們估計英國業務的換算匯率是 1.45 英鎊兌 1 美元。當然第一季的匯率低於這個水準,但你沒有看到對我們業務有任何重大影響。

  • And as of the last week or so the pound has strengthened. It's actually at GBP1.46 and some change. So right now our outlook is consistent, and obviously the Brexit vote is scheduled for June 22 or 23, so a lot of the activity around that will go away once the status is known one way or the other.

    而在最近一週左右,英鎊已經走強。實際上目前大約在 1.46 英鎊兌 1 美元再加一點。所以目前我們的展望是一致的;當然脫歐公投預定在 6 月 22 或 23 日,因此一旦結果不論哪一種確定下來,相關的波動與活動就會消退。

  • - Analyst

    - Analyst

  • And are there any hedges to offset that?

    那有沒有任何避險來抵消這些影響?

  • - Chairman and CEO

    - Chairman and CEO

  • Yes, we are working on that. To hedge some of the cash flow, we've got that addressed and we'll have an update going forward. But in order to take some of the noise out of that going forward, we are implementing a hedging program and certainly over a majority of the cash flows that we're reliant on out of the UK.

    有的,我們正在處理。為了對部分現金流進行避險,我們已經有相應安排,後續也會更新。但為了在未來降低這方面的雜訊,我們正在導入避險計畫,並且會涵蓋我們仰賴自英國匯出的多數現金流。

  • - Analyst

    - Analyst

  • Great. Thanks.

    很好。謝謝。

  • Yes, the revenue is certainly a surprise to the upside because it wouldn't have normally, so that's great. Appreciate it.

    是的,營收確實是超出預期的驚喜,因為通常不會這樣,所以很棒。感謝。

  • - Chairman and CEO

    - Chairman and CEO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • Whit Mayo, Robert W. Baird.

    Whit Mayo,Robert W. Baird。

  • - Analyst

    - Analyst

  • Good morning. I just wanted to focus in on the US same-store patient day growth for a minute. The numbers were pretty good, up 8%.

    早安。我想先聚焦一下美國同店病患日(patient day)成長。數字相當不錯,成長 8%。

  • Can you give us a sense of what the trends look like between the acute business, the RTC business, and the addiction business? Is any one growing faster than the other? Some of the optics with the admissions and the patient days, it can be a little hard for us to tell now with three or four different patients included within that segment.

    你能否說明一下急性照護業務、RTC 業務,以及成癮治療業務之間的趨勢?是否有哪一塊成長更快?從入院人次與病患日的呈現來看,現在這個分部包含三、四種不同病患類型,我們有時候不太容易判斷。

  • - Chairman and CEO

    - Chairman and CEO

  • Whit, this is Joey. If memory serves me right, the acute is obviously because we've built so many beds and bought beds on the acute side, that that is growing faster. The substance abuse is next and then the child and adolescent residential would be next.

    Whit,我是 Joey。如果我沒記錯,急性照護這塊顯然成長更快,因為我們在急性端新增了很多床位,也收購了床位。接下來是物質濫用(substance abuse),再來是兒童與青少年住宿式照護。

  • So we're getting great growth from the acute side of the business, and that's where we spent our money and that's where we built our beds. So that's what is occurring.

    所以我們在急性照護端的成長非常好,而那也是我們投入資金、建置床位的地方。所以目前就是這樣的情況。

  • - Analyst

    - Analyst

  • Makes sense. And maybe just an update on Sierra Tucson, how that's performing versus internal budgets and any way to size the contribution of that asset now?

    了解。另外想請你更新一下 Sierra Tucson 的狀況:相較於內部預算表現如何?以及目前是否能量化該資產的貢獻?

  • - Chairman and CEO

    - Chairman and CEO

  • Sierra Tucson is the one I referred to. They had their best quarter in six years.

    Sierra Tucson 就是我剛才提到的那一家。他們創下六年來最佳的一季。

  • - Analyst

    - Analyst

  • All right, I guess I'll leave it at that.

    好,那我就先到這裡。

  • And the last one maybe for David, if you can chime in and maybe help us out with the share count for the second quarter; D&A, interest expense, maybe run rate for rent, anything just to help us all get on the same page would be helpful.

    最後一題可能請 David 補充一下:第二季的股數;折舊與攤銷(D&A)、利息費用,還有租金的可能 run rate 等等;任何能幫助大家對齊假設的資訊都很有幫助。

  • - CFO

    - CFO

  • Okay, Whit, this is David.

    好的,Whit,我是 David。

  • First quarter of course reflected a partial quarter of activity around the shares that we issued during the quarter. So we see it going to about 87.6 million shares for the remainder of the year, of which would result in about $86.8 million on average for the year.

    第一季當然反映了我們在該季發行股份相關活動的部分季度影響。因此我們預期今年剩餘期間的股數大約會到 8,760 萬股,全年平均約為 8,680 萬股。

  • And then just to go through some of the other non-operating expenses that you mentioned, depreciation and amortization should be in the ballpark of $37 million or so a quarter. Of course that will increase as our revenue grows and as we have projects that come online that add to that number.

    再來就你提到的其他非營運費用部分,折舊與攤銷每季大約會在 3,700 萬美元左右。當然,隨著營收成長,以及有專案上線使該數字增加,這個金額也會上升。

  • So really percentage of revenue would be the right way to model that. Interest expense, of course the first quarter again reflects a partial quarter of the Priory financing, but it should be about $48 million per quarter for the remainder of the year.

    所以用營收占比來建模會是比較合適的方式。利息費用方面,第一季同樣反映了 Priory 融資的部分季度影響,但今年剩餘期間每季應該約為 4,800 萬美元。

  • - Analyst

    - Analyst

  • And rent expense, sorry.

    還有租金費用,不好意思。

  • - CFO

    - CFO

  • Rent expense we did see that increase some from the Priory acquisition, which adds about $40 million of rent expense to the business annually. So we should see that continue to increase to just under 3% of revenue for the remainder of the year. But then it should hold around that level.

    租金費用方面,我們確實看到因 Priory 收購而有所增加,該收購每年為業務增加約 4,000 萬美元的租金費用。因此今年剩餘期間租金費用占營收比重應會持續上升至略低於 3%。之後應會大致維持在那個水準。

  • - Analyst

    - Analyst

  • Awesome. Thanks. I appreciate it.

    太棒了。謝謝。很感謝。

  • Operator

    Operator

  • Gary Lieberman, Wells Fargo.

    Gary Lieberman,富國銀行。

  • - Analyst

    - Analyst

  • Thanks for taking the question. Just on the Priory and the CMA process, how has it gone versus your expectation? Have there been any surprises, and do you remain confident that you'll get full approval for it?

    謝謝讓我提問。就 Priory 與 CMA 的審查流程而言,進展和你們原先的預期相比如何?有沒有任何意外,你們是否仍有信心能獲得完整核准?

  • - Chairman and CEO

    - Chairman and CEO

  • No surprises. It appears that the consultants and lawyers that we use work well with the CMA staff. And we are kept up to date just about daily or once a week, and everything is tracking per their timeline and their process. So no negative surprises, and we do expect for them to approve the transaction. And we're okay, obviously we would have liked it to have gone faster, but they have their process and we have to live within that. So everything's going fine.

    沒有意外。看起來我們使用的顧問與律師和 CMA 的工作人員配合得很好。我們幾乎每天或每週都會收到最新進度,一切都依照他們的時程與流程在推進。所以沒有負面的意外,我們也預期他們會核准這筆交易。當然我們希望能更快,但他們有他們的流程,我們必須在那個框架內配合。所以一切都很順利。

  • - Analyst

    - Analyst

  • That's helpful.

    這很有幫助。

  • And then just going back to IMD. Is there any way for you to help us quantify either what the eventual impact is to volumes from the initial 75% that you'll be able to address, or just to give us some big picture numbers to help us try to quantify what the opportunity is there?

    另外回到 IMD。你們是否能協助我們量化:從一開始可處理的 75% 之後,最終對量的影響會是多少;或是提供一些宏觀數字,幫助我們估算那裡的機會有多大?

  • - Chairman and CEO

    - Chairman and CEO

  • Gary, I'm going to beg off on that. No. We don't know. And there's just too many moving parts to that. And you got to have the managed Medicaid penetration in the city that you're in, and there's too many moving variables.

    Gary,這題我先不回答。不行。我們不知道。而且變動因素太多。你還得看所在城市的管理式 Medicaid 滲透率,變數太多了。

  • But what we will do is after the third quarter we will have some experience with it, and we will be able to give you our thoughts then. But right now it would be too speculative for me to talk about the impact of this. But we'll have some information after the third quarter.

    不過我們會在第三季之後,因為會有一些實際經驗,到時候就能給你我們的看法。但現在談這個的影響會太過推測。第三季之後我們會有一些資訊。

  • - Analyst

    - Analyst

  • Okay, great. Thanks very much.

    好的,很好。非常感謝。

  • Operator

    Operator

  • Charles Haff, Craig-Hallum.

    Charles Haff,Craig-Hallum。

  • - Analyst

    - Analyst

  • Thanks for taking my question. Question for you on the same-store EBITDA margin, up 80 basis points year over year. I saw that length of stay declined on a same-store basis, same-store revenue per patient day went up a little bit.

    謝謝讓我提問。我想問同店 EBITDA 利潤率的問題,年增 80 個基點。我看到同店的住院天數(length of stay)下降,而同店每病患日收入(revenue per patient day)小幅上升。

  • But in light of those two lackluster factors, if you will, the same-store EBITDA margin went up very impressively. I'm just wondering when you think about your business if those two factors start to turn positive, how should we be thinking about same-store EBITDA margins in the future?

    但在這兩個相對平淡的因素之下,同店 EBITDA 利潤率卻非常亮眼地上升。我想請教,從你們的業務角度來看,如果這兩個因素開始轉為正向,我們應該如何看待未來的同店 EBITDA 利潤率?

  • - Chairman and CEO

    - Chairman and CEO

  • Okay, the 27.1% margin is a great margin for us, and it is 80 basis points over the first quarter of last year. Let me give you some information. This quarter last year 39% of our patient days were acute.

    好的,27.1% 的利潤率對我們來說很棒,且比去年第一季高 80 個基點。我補充一些資訊。去年同一季,我們的病患日有 39% 是急性(acute)。

  • This year 42% of them are acute. So that's what's causing the drop in the length of stay. The acute length of stay did actually tick up in the first quarter, but it is lower than the average.

    今年有 42% 是急性。這就是住院天數下降的原因。急性住院天數在第一季其實有小幅上升,但仍低於平均水準。

  • So it brought it down. And then on the revenue per day, we're pleased with the 50 basis points there, and that's a function of the mix of patients you have for that quarter. And so -- but I can talk about the length of stay. It's very stable, but we just did have more acute patient days and that's the reason for the decline.

    所以把整體拉低了。至於每病患日收入,我們對那 50 個基點的提升感到滿意,這取決於該季的病患組合。所以——但我可以談住院天數。它非常穩定,只是我們的急性病患日變多了,這就是下降的原因。

  • - Analyst

    - Analyst

  • Okay. I mean does it feel like you're firing on all cylinders on the same-store EBITDA margins given everything in your business, or do you think there is still potentially more improvement?

    了解。我的意思是,綜合你們業務的各項因素來看,你們是否覺得同店 EBITDA 利潤率已經火力全開,還是你們認為仍有進一步改善的空間?

  • - Chairman and CEO

    - Chairman and CEO

  • Obviously, when you look at total for the Company, we think there's improvement: obviously. And can we move, keep moving the same-store margins and the margins that are not in the same-store? I think so.

    顯然,當你看公司的整體,我們認為還有改善空間:當然。那我們能否持續推升同店利潤率,以及非同店的利潤率?我認為可以。

  • But most definitely these de novo projects that we have coming online, some of the acquisitions that we made where they have lower margins, our operations team is working very hard and improving those margins. So there is some margin improvement. But we'll just execute and deliver the results.

    尤其是我們正在上線的這些新設(de novo)專案,以及我們做的一些收購案(它們的利潤率較低),我們的營運團隊非常努力在改善那些利潤率。所以確實還有一些利潤率改善空間。但我們會專注執行並交出成果。

  • - Analyst

    - Analyst

  • Okay, great. Well congratulations, great quarter.

    好的,很好。恭喜,這一季表現很棒。

  • - Chairman and CEO

    - Chairman and CEO

  • Thank you.

    謝謝。

  • Operator

    Operator

  • Gary Taylor, JPMorgan.

    Gary Taylor,摩根大通。

  • - Analyst

    - Analyst

  • A couple quick questions. One, could you just update us at quarter end total US beds, total UK beds?

    兩個很快的問題。第一,能否更新一下季末美國總床位數、英國總床位數?

  • - CFO

    - CFO

  • Gary, this is David. In the US at the end of the quarter, we had 17,400 beds. Just over 8,000 of those were in the US and almost 9,400 of those were in the UK.

    Gary,我是 David。在美國,季末我們有 17,400 張床位。其中略高於 8,000 張在美國,接近 9,400 張在英國。

  • - Analyst

    - Analyst

  • Okay. And then my other question, Joey kind of touched on a little bit, I wanted to look on in the US either revenues, beds, or Joey just gave days that were acute. He said 39% of days. On either beds or revenues acute, could you help me on those?

    好的。第二個問題,Joey 剛剛稍微提到,我想看美國端不論是收入、床位,或 Joey 提到的急性病患日。他說病患日有 39%。就床位或收入的急性占比,你能幫我補充一下嗎?

  • - Chairman and CEO

    - Chairman and CEO

  • Number of acute beds? We can give you I think the number of acute beds we have. It's in the fine print, but we've got it here somewhere.

    急性床位數?我想我們可以給你急性床位數。在附註的小字裡,但我們這裡某處有。

  • - CFO

    - CFO

  • Here you go, Gary.

    給你,Gary。

  • And this is just in the US, of the 8,000 beds that I just mentioned, almost 3,300 of those were acute. And I'll just keep going through the list, we had about 2,800 specialty beds and almost 2,000 residential beds. That's how those break down.

    這只針對美國:在我剛提到的 8,000 張床位中,將近 3,300 張是急性床位。我再把分類說完:我們約有 2,800 張專科(specialty)床位,以及將近 2,000 張住宿式(residential)床位。大致就是這樣的拆分。

  • - Analyst

    - Analyst

  • Okay. Perfect. Thank you.

    好的。完美。謝謝。

  • - Chairman and CEO

    - Chairman and CEO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • John Ransom, Raymond James.

    John Ransom,Raymond James。

  • - Analyst

    - Analyst

  • This is an arcane question, but we had some old CBO forecast for IMD, something like $45 billion to $65 billion over 10 years. And I've been told those are both stale and maybe a bit inflated. Does anybody have any idea of when they're supposed to come out with new numbers on this?

    這是一個比較冷門的問題,但我們有一些舊的 CBO 對 IMD 的預測,大概是 10 年 450 億到 650 億美元。有人告訴我這些數字既過時、也可能有點被高估。有人知道他們大概什麼時候會公布新的估算數字嗎?

  • - President

    - President

  • John, this is Brent.

    John,我是 Brent。

  • I think as the IMD legislation continues to move through the respective houses of Congress, you're going to see an update. I don't know the exact time frame, but the $40 billion to $60 billion over 10 years again, everybody works hard and does their work, but there were some real flawed assumptions in that.

    我認為隨著 IMD 立法在國會兩院持續推進,你會看到更新。我不知道確切時間表,但 10 年 400 億到 600 億美元這個數字——大家都很努力做功課——但其中有一些非常有問題的假設。

  • So our industry association and everybody's working to frame that up. And then even when that number comes out, obviously this regulatory shift will reduce the total impact of what that remaining CBO estimate is, because that will have already been addressed through the managed Medicaid regulation adjustment. So we think it's going to be a much more manageable number when the actual revision comes out, but no specific clarity on when that would occur.

    所以我們的產業協會以及各方都在努力把這件事釐清。而且即便那個數字出來,顯然這次監管面的轉變也會降低剩餘 CBO 估算的總影響,因為其中一部分已經透過管理式 Medicaid 的監管調整被處理掉了。所以我們認為等到實際修正版本出來時,會是一個更可控的數字,但目前還不清楚會在何時發生。

  • - Analyst

    - Analyst

  • And then -- thanks that's great. My other question is that one of your competitors mentioned that states obviously have a -- they can opt in or opt out. How do you see that playing out?

    然後——謝謝,這很棒。我另一個問題是,你們的一位競爭對手提到,各州顯然有——他們可以選擇加入或選擇退出。你們認為這會如何發展?

  • - Chairman and CEO

    - Chairman and CEO

  • Well again, if you think about it's absolutely within the IMD managed Medicaid. Great news is it's in there, it's effective in 60 days.

    嗯,再次,如果你想想看,這絕對是在 IMD 管理式醫療補助(Medicaid)之內。好消息是它已經納入其中,並且在 60 天內生效。

  • But the states have to sign -- the states have to support it. We find it hard conceptually to know that there's under -- massive under capacity, real issues with access.

    但各州必須簽署——各州必須支持它。我們在概念上很難理解,因為目前存在——嚴重的容量不足,以及實際的可近性問題。

  • It just doesn't make sense in this environment that we wouldn't allow for the most appropriate providers to be able to treat the patients in need. So we think that while it is not a mandate, we don't see that as a significant detriment to the implementation of this updated reg.

    在這樣的環境下,如果我們不允許最合適的提供者來治療有需要的病患,這實在說不通。因此我們認為,雖然這不是強制規定,但我們不認為這會對這項更新法規的落實造成重大不利影響。

  • - Analyst

    - Analyst

  • Great.

    很好。

  • And just one question for David. As we think about your second-quarter EBITDA, who knows what the divestitures will be, can you just give us a rough breakout UK versus US as a percent?

    另外再問 David 一個問題。當我們思考你們第二季的 EBITDA 時,誰也不知道資產剝離會是什麼情況,你能否大致拆分一下英國與美國各占百分比?

  • - CFO

    - CFO

  • It's roughly 50/50 going forward based on the companies that we have right now. It breaks down roughly 50/50.

    以我們目前擁有的公司來看,往後大約是 50/50。大致上就是 50/50。

  • - Analyst

    - Analyst

  • So I'm just curious how your effective tax rate is almost a UK tax rate, given that. And do you see any -- is there any regulatory -- I know the Treasury Department is getting very excited about this stuff. But is there anything we need to think about relative to your tax rate going forward, or do you feel pretty comfortable with that?

    所以我只是好奇,在那樣的情況下,你們的有效稅率幾乎像是英國稅率。你是否看到任何——是否有任何監管——我知道財政部對這些事情變得非常興奮。但就你們未來的稅率而言,有沒有什麼我們需要考量的,還是你覺得相當安心?

  • - CFO

    - CFO

  • The tax rate is a function of the tax rules that are in place in the US and in the UK. So it's very much a unique calculation in each of our jurisdictions, of which is what gets it to the 23% expectation for the Company.

    稅率取決於美國與英國現行的稅務規則。因此在我們各個司法管轄區都有非常獨特的計算方式,而這也使公司預期稅率達到 23%。

  • There are tax rules in the US, of course, that came out in the first quarter that do not have a significant impact on us. There's tax legislation in the UK, as well, that we pay very close attention to, but there's nothing right now that would have a significant impact on us from a tax perspective.

    當然,美國在第一季推出了一些稅務規則,對我們沒有重大影響。英國也有稅務立法,我們同樣密切關注,但目前從稅務角度來看,沒有任何會對我們造成重大影響的事項。

  • - Analyst

    - Analyst

  • Okay. Thanks a lot.

    好的。非常感謝。

  • - CFO

    - CFO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • Dana Hambly, Stephens.

    Dana Hambly,Stephens。

  • - Analyst

    - Analyst

  • Thanks.

    謝謝。

  • Joey, just the CTC market, you read about opiate abuse every day now. Is this a market that the infrastructure is in place in the US, or is it one where we need to dedicate a lot more resources and you grow that more via de novo versus acquisition? Or how do you think about that?

    Joey,就 CTC 市場而言,你現在每天都會看到關於鴉片類藥物濫用的報導。這個市場在美國的基礎設施是否已經到位,還是我們需要投入更多資源,並且更多透過新設(de novo)而非併購來成長?或者你是如何看待這件事的?

  • - Chairman and CEO

    - Chairman and CEO

  • That is a combination strategy. We are aggressive on the de novos. If we can do 5 to 10 of those a year, that would be great for us.

    這是一個組合策略。我們在新設(de novo)方面很積極。如果我們一年能做 5 到 10 個,那對我們會很棒。

  • But we're also looking for an acquisition in this space, so we're doing both. And you're absolutely right, it's in the daily news this issue, and we're trying to -- in the markets that we're in we're trying to make sure that we're meeting their needs, and if there needs to be a new de novo we're doing those. So it's a combination strategy; de novos and acquisitions.

    但我們也在這個領域尋找併購機會,所以兩者都在做。而你說得完全正確,這個議題每天都在新聞上,我們正努力——在我們所在的市場,確保我們能滿足他們的需求;如果需要新設(de novo),我們就會去做。所以這是一個組合策略:新設(de novo)與併購。

  • - Analyst

    - Analyst

  • Okay. And how quickly can those be open? It doesn't seem like there's much infrastructure there. Is it just more regulatory is the issue with getting those open?

    好的。那這些能多快開業?看起來那裡的基礎設施並不多。開業的問題主要只是監管嗎?

  • - Chairman and CEO

    - Chairman and CEO

  • It's just getting through the regulatory process, less than six months. It's controlled by the regulatory process.

    主要就是走完監管流程,不到六個月。一切都取決於監管流程。

  • - Analyst

    - Analyst

  • Okay.

    好的。

  • And then just last one for me on the CapEx in the quarter, I was using about $150,000 per bed and then assuming 2.5% corporate CapEx. And I wasn't really getting anywhere close to $90 million in the quarter. Is there anything else driving that this quarter?

    然後我最後一個問題是關於本季的資本支出(CapEx)。我用每床約 150,000 美元,並假設公司層級 CapEx 為 2.5%。但我怎麼算都離本季的 9,000 萬美元差很遠。本季還有其他因素在推動嗎?

  • - CFO

    - CFO

  • Dana, this is David. Our maintenance CapEx was about 2.9% of our revenue. We did have -- out of our $90 million of capital expenditures, $72 million of that relates to our expansion.

    Dana,我是 David。我們的維護性資本支出約為營收的 2.9%。在我們 9,000 萬美元的資本支出中,有 7,200 萬美元與我們的擴張相關。

  • We added 330 beds during the quarter, some of that would be represented by de novo projects. But I think the metric maybe in the ballpark of what you're looking for if you use the $72 million of expansion CapEx and the beds that we have added during the quarter.

    我們在本季新增了 330 張床位,其中一部分會反映在新設(de novo)專案上。但我認為,如果你用 7,200 萬美元的擴張 CapEx 以及本季新增的床位數來看,這個指標大概就會接近你在看的數字。

  • - Analyst

    - Analyst

  • Okay. That's helpful. Thanks.

    好的。這很有幫助。謝謝。

  • - CFO

    - CFO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • And, ladies and gentlemen, that will conclude our Q&A session for today. I would like to turn the call back over to Mr. Joey Jacobs for closing remarks.

    各位女士、先生,今天的問答環節到此結束。我想把電話交回給 Joey Jacobs 先生作結語。

  • - Chairman and CEO

    - Chairman and CEO

  • Sure. I want to thank everyone for joining us on the call today. For the team here at Acadia that are listening in, thank you very much for all that you're doing.

    好的。感謝各位今天加入我們的電話會議。對於在 Acadia 這裡收聽的團隊成員,非常感謝你們所做的一切。

  • We're very, very proud of what you're doing on a daily basis in taking care of our patients. And once again, thank you for being a part of the family here at Acadia, and we'll look forward to talking to you all on the next earnings call.

    我們非常、非常以你們每天照護病患所做的工作為榮。再次感謝你們成為 Acadia 這個大家庭的一員,我們期待在下一次財報電話會議再與各位交流。

  • Operator

    Operator

  • That will conclude today's conference. Thank you all for your participation.

    今天的會議到此結束。感謝各位的參與。